<DOC>
	<DOCNO>NCT03069300</DOCNO>
	<brief_summary>Recent data suggest monocyte oxidative burst defect associate development infection patient severe alcoholic hepatitis . One report find reduced 28 day mortality patient treat N-acetylcysteine combine prednisolone compare prednisolone alone . The current study seek reveal whether mechanism NAC reduce susceptibility infection improvement phagocyte oxidative burst .</brief_summary>
	<brief_title>N-ACetylcysteine Reduce Infection Mortality Alcoholic Hepatitis</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Aged 18 year old Clinical alcoholic hepatitis : Serum bilirubin &gt; 80umol/L History alcohol excess ( &gt; 80g/day male , &gt; 60g/day female ) Less 4 week since admission hospital Maddrey 's discriminant function ( DF ) &gt; 32 Informed consent Alcohol abstinence &gt; 6 week prior randomisation Duration jaundice &gt; 3 month Other cause liver disease include : Evidence viral hepatitis ( hepatitis B C ) Biliary obstruction Hepatocellular carcinoma Evidence current malignancy ( except nonmelanotic skin cancer ) Previous entry study Patients know hypersensitivity previous reaction NAC Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>